Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Gastrointestinal Cancer Research : GCR
|
February 2, 2012
Rationing care: stifling progress while increasing cost of cancer care
Jamal Misleh
The American Journal of the Medical Sciences
|
November 9, 2012
Looking beyond the test
James Perkins, Jamal Misleh
Cancer
|
September 2, 2016
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113
Rachel E Sanborn, Jyoti D Patel, Gregory A Masters, et al.
Clinical Epigenetics
|
March 15, 2019
Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study
Song Yao, Qiang Hu, Sarah Kerns, et al.
Journal of the American Geriatrics Society
|
April 30, 2019
Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer
Allison Magnuson, Lianlian Lei, Nikesha Gilmore, et al.
Blood Advances
|
May 7, 2025
Zanubrutinib is well tolerated and effective in CLL/SLL patients intolerant of ibrutinib/acalabrutinib: Updated results
Mazyar Shadman, John M Burke, Jennifer Cultrera, et al.
JNCI Cancer Spectrum
|
October 31, 2025
Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy
Hongying Sun, Umang Gada, Riham Alieldin, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Robert L Ferris, Rom S Leidner, Christine H Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
Haematologica
|
January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
Linlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Gastrointestinal Cancer Research : GCR
|
February 2, 2012
Rationing care: stifling progress while increasing cost of cancer care
Jamal Misleh
The American Journal of the Medical Sciences
|
November 9, 2012
Looking beyond the test
James Perkins, Jamal Misleh
Cancer
|
September 2, 2016
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113
Rachel E Sanborn, Jyoti D Patel, Gregory A Masters, et al.
Clinical Epigenetics
|
March 15, 2019
Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study
Song Yao, Qiang Hu, Sarah Kerns, et al.
Journal of the American Geriatrics Society
|
April 30, 2019
Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer
Allison Magnuson, Lianlian Lei, Nikesha Gilmore, et al.
Blood Advances
|
May 7, 2025
Zanubrutinib is well tolerated and effective in CLL/SLL patients intolerant of ibrutinib/acalabrutinib: Updated results
Mazyar Shadman, John M Burke, Jennifer Cultrera, et al.
JNCI Cancer Spectrum
|
October 31, 2025
Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy
Hongying Sun, Umang Gada, Riham Alieldin, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Robert L Ferris, Rom S Leidner, Christine H Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
Haematologica
|
January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
Linlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Page
of 2